1. National Safety Council, 2017. Injury Facts, 2017 Edition
2. Premier Inc. Analysis, Jan 2019
While the challenges are complex, healthcare providers and payers have the data necessary to provide a fact base of prescribing practices and potential drug diversion. They can use this to approach the problem in a multifaceted way that can potentially both mitigate risk and lower long-term costs.
PwC’s Controlled Substance Solutions deliver an understanding of your current state, a baseline of information to help you take action to tackle these issues and a process for monitoring progress.
We provide ongoing visibility into provider prescribing practices and potential drug diversion.
This can spark necessary conversations about enhanced standards of care and strategic initiatives in line with your social and regulatory responsibilities and risk tolerance.
This lays the foundation for you to begin using predictive analytics to help identify and engage those most at risk.
Data that's useful in detecting potential diversion sits across multiple systems, including EHRs, resource scheduling apps, time cards, drug dispensing systems and physical access control systems. Brought together, new insights can be unlocked.
Regulatory requirements are changing quickly and vary across local, state and federal agencies. Understanding them is the first step, and using your data to monitor compliance should be the next.
Detecting and treating substance use disorder can improve a patient's health while reducing overall cost of care. New legislation and regulations are requiring more from providers, but they are also creating new opportunities.